Rapid Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol Using Genotype MTBDRsl Assay: A Meta-Analysis

Feng, Yan; Liu, Sijun; Wang, Qungang; Wang, Liang; Tang, Shaowen; Wang, Jianming; Lu, Wei
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: There are urgent needs for rapid and accurate drug susceptibility testing of M. tuberculosis. GenoType MTBDRsl is a new molecular kit designed for rapid identification of the resistance to the second-line antituberculosis drugs with a single strip. In recent years, it has been evaluated in many settings, but with varied results. The aim of this meta-analysis was to synthesize the latest data on the diagnostic accuracy of GenoType MTBDRsl in detecting drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol, in comparison with the phenotypic drug susceptibility test. Methods: This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The search terms of “MTBDRsl” and “tuberculosis” were used on PubMed, EMBASE, and Web of Science. QUADAS-2 was used to assess the quality of included studies. Data were analyzed by Meta-Disc 1.4. We calculated the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and corresponding 95% confidence interval (CI) for each study. From these calculations, forest plots and summary receiver operating characteristic (SROC) curves were produced. Results: Patient selection bias as well as flow and timing bias were observed in most studies. The summarized sensitivity (95% CI) was 0.874(0.845–0.899), 0.826(0.777–0.869), 0.820(0.772–0.862), 0.444(0.396–0.492), and 0.679(0.652–0.706) for fluoroquinolones, amikacin, capreomycin, kanamycin, and ethambutol, respectively. The specificity (95% CI) was 0.971(0.961–0.980), 0.995(0.987–0.998), 0.973(0.963–0.981), 0.993(0.985–0.997), and 0.799(0.773–0.823), respectively. The AUC (standard error) were 0.9754(0.0203), 0.9300(0.0598), 0.9885(0.0038), 0.9689(0.0359), and 0.6846(0.0550), respectively. Conclusion: Genotype MTBDRsl showed good accuracy for detecting drug resistance to fluoroquinolones, amikacin and capreomycin, but it may not be an appropriate choice for kanamycin and ethambutol. The lack of data did not allow for proper evaluation of the test on clinical specimens. Further systematic assessment of diagnostic performance should be carried out on direct clinical samples.


Related Articles

  • Drug resistance and Susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre. Azura, S.; Hussin, S.; Rahman, Md. Mostafizur // Pakistan Journal of Medical Sciences;Oct2011, Vol. 27 Issue 5, p1107 

    Objective: The prime objective of the study was to evaluate drug resistance and susceptibility of Mycobacterium tuberculosis isolated at University Kebangsaan Malaysia Medical Centre. Methodology: A total number of 726 specimens in the form of sputum and bronchial lavage obtained from patients...

  • Determination of Minimum Inhibitory Concentration Values of Ethambutol for Mycobacterium Tuberculosis. J., Rajeeta; Shah, K. U. // Indian Journal of Public Health Research & Development;Apr-Jun2014, Vol. 5 Issue 2, p30 

    Background: Tuberculosis has always been and still has the distinction of being a leading contender for one of the top places on the list of the main cause of death in India. Ethambutol is a narrowspectrum antimycobacterial agent that is used for the treatment of tuberculosis. At times the...

  • The role of eis mutations in the development of kanamycin resistance in Mycobacterium tuberculosis isolates from the Moscow region. Gikalo, Marina B.; Nosova, Elena Y.; Krylova, Ludmila Y.; Moroz, Arkadyi M. // Journal of Antimicrobial Chemotherapy (JAC);Sep2012, Vol. 67 Issue 9, p2107 

    Objectives Kanamycin is an important second-line drug used to treat multidrug-resistant (MDR) tuberculosis (TB). Molecular analysis of the rrs gene seems to be not enough to identify every case of kanamycin resistance. In the present study we evaluated the incidence of eis mutations in...

  • Specific gyrA gene mutations predict poor treatment outcome in MDR-TB. Rigouts, L.; Coeck, N.; Gumusboga, M.; de Rijk, W. B.; Aung, K. J. M.; Hossain, M. A.; Fissette, K.; Rieder, H. L.; Meehan, C. J.; de Jong, B. C.; Van Deun, A. // Nicotine & Tobacco Research;Feb2016, Vol. 18 Issue 2, p314 

    Objectives: Mutations in the gyrase genes cause fluoroquinolone resistance in Mycobacterium tuberculosis. However, the predictive value of these markers for clinical outcomes in patients with MDR-TB is unknown to date. The objective of this study was to determine molecular markers...

  • Researchers identify 39 genes related to TB drug resistance. Shafer, Emily; Volansky, Rob; Zacharyczuk, Colleen // Infectious Disease News;Oct2013, Vol. 26 Issue 10, p40 

    The article discusses a study published in a 2013 issue of the periodical "Nature Genetics" that reported the identification of 39 new genes associated with drug resistance in Mycobacterium tuberculosis.

  • Recent advances in the diagnosis and treatment of childhood tuberculosis. Kumar, Mani Kant; Kumar, Prashant; Singh, Anjali // Journal of Natural Science, Biology & Medicine;Jul-Dec2015, Vol. 6 Issue 2, p314 

    Despite over 2.3 million (26% of global burden) cases of tuberculosis (TB) in India the accurate diagnosis of childhood TB remains a major challenge. Children with TB usually have paucibacillary disease and contribute little to disease transmission within the community. Consequently the...

  • Extensively Drug-Resistant Tubercalosis: "There must be some kind of way out of here". Cegielski, J. Peter // Clinical Infectious Diseases;5/15/2010 Supplement 3, Vol. 50, pS195 

    Over the past 7 decades, Mycobacterium tuberculosis has developed resistance to virtually every new drug used to treat tuberculosis, resulting recently in the global emergence of extensively drug-resistant tuberculosis. In an individual, treatment with a single new drug results in acquired drug...

  • Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis. Dookie, Navisha; Sturm, A. Willem; Moodley, Prashini // Infection & Drug Resistance;2014, Vol. 7, p223 

    Objectives: Moxifloxacin (MXF) has been advocated for the treatment of extensively drugresistant (XDR) tuberculosis despite resistance to older-generation fluoroquinolones. We investigated the relationship between the minimum inhibitory concentration (MIC) of MXF and mutations in the gyrA and...

  • Polyamines Inhibit Porin-Mediated Fluoroquinolone Uptake in Mycobacteria. Sarathy, Jansy Passiflora; Lee, Edmund; Dartois, Véronique // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Polyamines decrease the permeability of the outer membrane of Escherichia coli to fluoroquinolones and β-lactams. In this study, we tested the effect of four polyamines (spermidine, spermine, cadaverine and putrescine) on fluoroquinolone uptake in Mycobacterium bovis BCG. Our results show...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics